SEC Form 4/A · accession 0001511164-16-001083
Lotus Biotech Development Corp. · LBTD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Zoltan Nagy
Other
Period of report
Oct 1, 2016
Accepted (ET)
Oct 17, 2016 · 10:50 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Lotus Bio-Technology Dev. Corp | Oct 1, 2016 | S | 50,000,000 | $0.001 | A | 0 | I | Ex President/CEO |
Table II — derivative securities
No Table II lines on this filing.